Status:

COMPLETED

Pediatric Type 1 Diabetes and Neurocognitive Complications Cohort Study

Lead Sponsor:

Vanderbilt University Medical Center

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions:

Type 1 Diabetes

Eligibility:

All Genders

6-11 years

Brief Summary

The proposed project will assess hypothesized risk factors (age of onset, Diabetic ketoacidosis (DKA) at presentation and glycemic control), as well as potentially modifiable protective factors (child...

Detailed Description

The onset of type 1 diabetes (T1D) in childhood results in clinically significant deficits in neurocognitive functioning that manifest in adulthood. These deficits have implications for adaptive funct...

Eligibility Criteria

Inclusion

  • Pediatric T1D sample: Children will be eligible if they meet the following inclusion/exclusion criteria:
  • are between 6 -11 years of age
  • have no history of afebrile seizure (not related to hypoglycemia) or sleep disorders other than insufficient sleep or insomnia
  • no contraindications to high quality MRI of the brain (no metal implants or braces)
  • no premature birth (\<34 weeks) or low birth weight (\<2,000g).
  • Comparison sample: Children will be eligible if they meet the following inclusion/exclusion criteria:
  • no known chronic medical conditions or intellectual disability
  • no known history of concussion or traumatic brain injury
  • no history of afebrile seizure; (4) no braces or metal implants
  • (5) no premature birth (\<34 weeks) or low birth weight (\<2,000g).
  • Parents or primary caregivers of all children will be eligible if they:
  • live with the child
  • read/speak English to allow use of validated parental questionnaires. The parent who is the primary caregiver of the child will be invited to participate.

Exclusion

  • N/A

Key Trial Info

Start Date :

January 18 2021

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 31 2022

Estimated Enrollment :

12 Patients enrolled

Trial Details

Trial ID

NCT04135365

Start Date

January 18 2021

End Date

October 31 2022

Last Update

November 1 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Vanderbilt University Medical Center

Nashville, Tennessee, United States, 37232